BSE filing, NSE: SHILPAMED. Summary written from the filing by ALFA Finder's alert engine.
Shilpa Medicare Ltd: key numbers
- Share price
- ₹932.80
- Market cap
- ₹18,244 Cr
- Revenue (annual)
- ₹1,539 Cr
- Net profit (annual)
- ₹243.3 Cr
- P/E (TTM)
- 61.4×Sector 46.1×
- Promoter holding
- 40.13%+0.00% QoQ
- FII holding
- 12.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shilpa Medicare Ltd
All →Shilpa Medicare Business Update
Shilpa Medicare Limited’s Unit 4 in Jadcherla received GMP certification from AGES, Austria, following a successful inspection. This milestone enables operations for European and global markets.
Shilpa Medicare Other Announcement
Shilpa Medicare Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Shilpa Medicare Other Announcement
Shilpa Medicare Ltd KMP Alpesh Maheshkumar Dalal sold 4,000 equity shares via market sale. The transaction was valued at Rs.0.42 Crore and executed on the NSE.
- Value
- ₹0.42 Cr
Shilpa Medicare Share Pledge
The company's promoters reported the release of encumbrance on 30,00,000 equity shares held by them. This reduction in pledged shares signals a change in promoter leverage.
Shilpa Medicare Other Announcement
Shilpa Medicare received a 'Crisil ESG 59' rating from CRISIL ESG Ratings for FY2026. This is a routine regulatory disclosure under Regulation 30 with no financial implications.
Shilpa Medicare Business Update
Shilpa Medicare reported a USFDA surveillance inspection at its Unit VII Analytical Services Division. The inspection resulted in one procedural observation with no material impact on operations.
Other board meeting date announcements
All →Shriram Asset Management Company Board Meeting Date
Shriram AMC has scheduled its Board meeting for 5 November 2026 to consider unaudited Q1 and H1 FY27 financial results. No decisions or figures are reported in this intimation.
Pearl Global Industries Board Meeting Date
Pearl Global Industries intimated a Board meeting on November 5, 2026, to consider Q2 and H1 FY27 results and any interim dividend. No financial figures or decisions are reported yet.
Tenneco Clean Air India Board Meeting Date
Tenneco Clean Air India Ltd scheduled a board meeting for November 04, 2026 to approve unaudited Q2/H1 results. No monetary value or operational detail is disclosed in this intimation.
Athena Constructions Board Meeting Date
Athena Constructions scheduled a board meeting for 5 November 2026 to consider its half-year results. The trading window is closed and will reopen after results are declared.
Prime Fresh Board Meeting Date
Prime Fresh scheduled its Board meeting for 06 November 2026 to approve unaudited Q1 and H1 results. Trading window closed from 01 October 2026.
Pokarna Board Meeting Date
Pokarna Ltd intimated that its Board meets on 03 Nov 2026 to consider unaudited Q1 and H1 FY27 results. The trading window stays closed till 05 Nov 2026.